KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $124.0 million.

  • Quest Diagnostics' Change in Accured Expenses rose 127777.78% to $124.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $148.0 million, marking a year-over-year increase of 10000.0%. This contributed to the annual value of -$67.0 million for FY2024, which is 2181.82% down from last year.
  • Latest data reveals that Quest Diagnostics reported Change in Accured Expenses of $124.0 million as of Q3 2025, which was up 127777.78% from $42.0 million recorded in Q2 2025.
  • Quest Diagnostics' Change in Accured Expenses' 5-year high stood at $235.0 million during Q3 2021, with a 5-year trough of -$211.0 million in Q1 2023.
  • Its 5-year average for Change in Accured Expenses is -$6.5 million, with a median of $9.0 million in 2024.
  • In the last 5 years, Quest Diagnostics' Change in Accured Expenses surged by 210000.0% in 2022 and then tumbled by 33437.5% in 2023.
  • Over the past 5 years, Quest Diagnostics' Change in Accured Expenses (Quarter) stood at -$1.0 million in 2021, then surged by 2100.0% to $20.0 million in 2022, then surged by 780.0% to $176.0 million in 2023, then plummeted by 80.11% to $35.0 million in 2024, then skyrocketed by 254.29% to $124.0 million in 2025.
  • Its last three reported values are $124.0 million in Q3 2025, $42.0 million for Q2 2025, and -$53.0 million during Q1 2025.